A study in Chemistry A European Journal reveals that reduced MUC1 antigen density on gold nanoparticles still elicits potent ...

While research in mice has shown encouraging results, the next phases of human trials will need to confirm safety and ...

Quanyin Hu, a professor in the UW-Madison School of Pharmacy, said the approach could theoretically be applied to any cancer ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing ...

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...

At the heart of innovation is T-win®, a groundbreaking vaccine platform that could change how we treat cancer.

Together, they developed a vaccine that trains the immune system to recognize and attack pancreatic cancer cells. The vaccine ...

We could be on the verge of a major cancer treatment breakthrough, with a new vaccine shown to completely obliterate pancreatic cancer cells in preclinical trials. This paves the way for it to move ...

US researchers have found that developing personalised vaccines can play a key role in keeping aggressive tumours from ...